Gemcitabine Hydrochloride | Interleukin Related interleukin-related.com

Product Name :
Gemcitabine Hydrochloride

Search keywords :
Gemcitabine (hydrochloride)

drugId :
null

Target Vo:
DNA

Target Vo Short Name :
DNA

Moa_Name:
Ribonucleotide reductase inhibitors

First Approval Country :
South Africa

First Approval Date Filter:
1995

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Ain Shams University

Active Indication_Name:
Lymphoma

In Active Indication_Name:
Leukemia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PTEN Antibody
Myosin heavy chain Antibody
HDAC4 Antibody: HDAC4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 120 kDa, targeting to HDAC4. It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts